SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Phase I-II

Supplier Webinars Videos, Audio, Infographics Technical Papers Product Brochures Press Releases SUPPLIERS LIST
All Product Information
1 to 10 of 72 results Page 1 2 3 > Results per page

Seeking Drug Approval via the 505(b)(2) NDA Option

QPS | 07-May-2015 | PDF Technical / white paper
Today, many pharmaceutical companies are choosing the 505(b)(2) New Drug Approval (NDA) regulatory pathway. The 505(b)(2) NDA route relie...

How Sponsors and CROs Benefit From EDC Efficiencies

Merge Healthcare | 01-Apr-2015 | PDF Technical / white paper
Intense competition in the prescription drug market is driving pharmaceutical companies to expedite their drug discovery and development...
Early Alzheimer’s Disease and patient recruitment

Early Alzheimer’s Disease and patient recruitment

CCBR COMPANY INFORMATION | 30-Mar-2015 | PDF Research study
The increasing challenges in delivering patient enrolment, treatment and retention in clinical trials exist in all Therapeutic Areas but...

The whole blood assay: Detection of broad spectrum of pyrogens & examples of medical device testing

Merck Millipore microbial industry | 09-Apr-2015 | Webinar On-Demand Supplier Webinar
Pyrogens in pharmaceuticals, medical devices, biotherapeutics and cosmetics can cause fevers in humans and are potentially life-threateni...
Broad spectrum pyrogen detection according to pharmacopoeia

Broad spectrum pyrogen detection

EMD Millipore | 02-Dec-2014 | PDF Application note
The Monocyte-Activation Test (MAT), which was introduced into the European Pharmacopoeia in 2010, detects pyrogens in pharmaceuticals. It...
Broad spectrum pyrogen detection according to pharmacopoeia

Broad spectrum pyrogen detection according to pharmacopoeia

Merck Millipore microbial industry | 01-Dec-2014 | PDF Application note
The Monocyte-Activation Test (MAT), which was introduced into the European Pharmacopoeia in 2010, detects pyrogens in pharmaceuticals. It...

Mobile ePRO makes a difference: Trigemina’s TI-001 formulation including intranasal oxytocin clinical study

Exco InTouch | 18-Nov-2014 | PDF Case study
Trigemina is a clinical stage specialty pharmaceutical company that develops non-narcotic, nasally delivered, analgesic drug products inc...

Veristat and Karyopharm Therapeutics Inc. Agreement

Veristat, LLC | 20-Jun-2014 | Press Release Press release
HOLLISTON, Mass. – June 15, 2014 – Veristat, a full service Contract Research Organization, announced today that Karyopharm Therapeutics...

Learn the risk factors of metabolic syndrome and the role central labs play in aiding its detection

ACM Global Central Laboratory | 17-Jun-2014 | PDF Clinical study
Metabolic syndrome, a serious condition impacting adults and children in all genders, races and ethnicities, can lead to fatal outcomes i...
Industry leading titers of protein in E.coli

Industry leading titers of protein in E.coli

Fujifilm | 28-May-2014 | Webinar On-Demand Supplier Webinar
The development of large scale E. coli expression systems can be rate limiting in process development.  Fujifilm's pAVEway™ system c...
1 to 10 of 72 results Page 1 2 3 > Results per page

Related News

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Product Innovation